Parkman Healthcare Partners LLC
Top Portfolio Positions
89 positions ·
$964,562,654 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SYK |
Stryker Corp
Healthcare
|
154,771 | $50,856,202 | 5.27% | |
| DXCM |
Dexcom Inc
Healthcare
|
689,822 | $43,320,821 | 4.49% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
1,835,506 | $36,948,735 | 3.83% | |
| PODD |
Insulet Corp
Healthcare
|
156,561 | $32,852,760 | 3.41% | |
| LLY |
ELI LILLY & Co
Healthcare
|
34,616 | $31,838,758 | 3.30% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
431,364 | $29,388,829 | 3.05% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
497,035 | $28,902,585 | 3.00% | |
| BSX |
Boston Scientific Corp
Healthcare
|
448,768 | $28,160,192 | 2.92% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
387,306 | $27,816,316 | 2.88% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
1,207,274 | $26,077,118 | 2.70% |
Portfolio Trend
25 quarters · across all stocks
Holdings in URGN
Shares Held
Position Value (USD)
11 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,944,500 | 275,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,952,546 | 168,768 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,031,770 | 402,595 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,420,817 | 176,702 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,348,272 | 393,153 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,939,019 | 369,861 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,413,770 | 347,541 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,605,522 | 274,465 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,762,760 | 184,184 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,632,500 | 175,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,035,807 | 145,311 | Shares | Sole | 2023-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||